SCHEMBL10028151

SCHEMBL10028151

Cc1ccccc1-c1ccc2cc3oc4ccc5c6cc(-c7ccccc7C)ccc6cc6oc7ccc(c2c1)c3c7-c4c65

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSD P07339 1/20 0.39
BACE1 P56817 1/20 0.39
CLK4 Q9HAZ1 8/20 0.39
CYP2C19 P33261 8/20 0.39
CYP1A2 P05177 8/20 0.39
ALDH1A1 P00352 8/20 0.39
TSHR P16473 7/20 0.39
CYP3A4 P08684 7/20 0.39
CYP2D6 P10635 5/20 0.39
MAPK1 P28482 4/20 0.39
CYP2C9 P11712 4/20 0.39
HIF1A Q16665 2/20 0.36
TRPA1 O75762 1/20 0.36
PRMT5 O14744 1/20 0.36
WDR77 Q9BQA1 1/20 0.36
KIT P10721 1/20 0.36
KDM4E B2RXH2 3/20 0.35
TP53 P04637 3/20 0.35
HSD17B10 Q99714 3/20 0.35
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10028145 0.86 WEE1 (0.40) CYP2C19CYP1A2ALDH1A1CYP3A4CYP2D6
SCHEMBL10028158 0.84 AHR (0.41) BACE1CYP1A2TRPA1HPGDNPC1
SCHEMBL10028146 0.84 MCL1 (0.38) CYP2C19CYP1A2ALDH1A1TSHRCYP3A4
SCHEMBL10028082 0.79 CTSD (0.40) CTSDBACE1CYP2C19CYP1A2ALDH1A1
SCHEMBL16625735 0.76 CLK4 (0.48) CTSDBACE1CLK4CYP2C19CYP1A2
SCHEMBL27308763 0.76 CLK4 (0.43) CTSDBACE1CLK4CYP2C19CYP1A2
SCHEMBL16639344 0.75 NPC1 (0.40) CYP2C19CYP1A2ALDH1A1TSHRCYP2C9
SCHEMBL10028239 0.74 AHR (0.46) CYP1A2ALDH1A1TSHRMAPK1HIF1A
SCHEMBL16852487 0.73 ALDH1A1 (0.49) CLK4CYP2C19CYP1A2ALDH1A1TSHR
SCHEMBL10028107 0.71 GSTP1 (0.44) CLK4CYP1A2ALDH1A1TSHRCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2046915-B1 NEW MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2015-12-02 EP disclosed
US-8114531-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2012-02-14 US disclosed
US-8114531-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2012-02-14 US disclosed
US-20100013381-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2010-01-21 US disclosed
US-20100013381-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2010-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100013381-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES L1CAM, SOD1, SLC40A1 CTSD 3083/4885BACE1 2454/4885CLK4 4761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.